Features | Partner Sites | Information | LinkXpress
Sign In
PURITAN MEDICAL
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Antimicrobial Hydrogels Dissolve and Sterilize Drug-Resistant Biofilms

By BiotechDaily International staff writers
Posted on 04 Feb 2013
Image: The polymer solution is free flowing (b, d) at room temperature (25 °C). When heated to body temperature (37 °C), the polymers self-assemble into a cross-linked network, causing the solution to form a gel (c, e) (Photo courtesy of IBM).
Image: The polymer solution is free flowing (b, d) at room temperature (25 °C). When heated to body temperature (37 °C), the polymers self-assemble into a cross-linked network, causing the solution to form a gel (c, e) (Photo courtesy of IBM).
Image: On the left is a mature and healthy MRSA biofilm. After the hydrogel is applied, the biofilm is destroyed as seen on the right. The small portion of cells left has drastically disrupted membrane, preventing resistance. This type of biofilm disruption has not been reported in other antimicrobial hydrogels/synthetic polymers (Photo courtesy of IBN).
Image: On the left is a mature and healthy MRSA biofilm. After the hydrogel is applied, the biofilm is destroyed as seen on the right. The small portion of cells left has drastically disrupted membrane, preventing resistance. This type of biofilm disruption has not been reported in other antimicrobial hydrogels/synthetic polymers (Photo courtesy of IBN).
Synthetic antimicrobial hydrogels have been developed that demonstrate 100% efficiency in destruction of biofilms, with application potential for catheter and medical device coatings, implants, skin, and everyday surfaces.

Bacterial biofilms, which are adhesive groupings of pathogenic cells present in 80% of all infections, develop on the skin and on medical devices and household surfaces where they are difficult to treat and demonstrate high resistance to antibiotics.

In the current study, which was published in the January 7, 2013, issue of the journal, Angewandte Chemie, investigators at IBM (San Jose, CA, USA) and the Institute of Bioengineering and Nanotechnology (Singapore) described the development of biodegradable and injectable/moldable hydrogels with hierarchical nanostructures. These 90% aqueous hydrogels were made from specifically designed macromolecules containing a large number of atoms, which combined water solubility, positive charge, and biodegradability characteristics. When mixed with water and warmed to body temperature the polymers self-assembled, swelling into a synthetic gel that was easy to manipulate.

The hydrogels were shown to possess broad-spectrum antimicrobial activities and biofilm-disruption capability. Furthermore, they demonstrated no cytotoxicity in vitro, and displayed excellent skin biocompatibility in animals.

"This is a fundamentally different approach to fighting drug-resistant biofilms. When compared to capabilities of modern-day antibiotics and hydrogels, this new technology carries immense potential,” said Dr. James Hedrick, advanced organic materials scientist at IBM. “This new technology is appearing at a crucial time as traditional chemical and biological techniques for dealing with drug-resistant bacteria and infectious diseases are increasingly problematic.”

“We were driven to develop a more effective therapy against super bugs due to the lethal threat of infection by these rapidly mutating microbes and the lack of novel antimicrobial drugs to fight them. Using the inexpensive and versatile polymer materials that we have developed jointly with IBM, we can now launch a nimble, multipronged attack on drug-resistant biofilms which would help to improve medical and health outcomes,” said Dr. Yi-Yan Yang, group leader at the Institute of Bioengineering and Nanotechnology.

Related Links:
IBM
Institute of Bioengineering and Nanotechnology


Channels

Genomics/Proteomics

view channel
Image: Cholesterol–shown here in hamster ovary cells—is a building block of steroid hormones that trigger puberty and support pregnancy (Photo courtesy of Dr. D. Ory, Washington University School of Medicine).

Cholesterol Trafficking in the Mouse Embryo Is Regulated by a snoRNA

Cellular cholesterol trafficking in mouse embryos was found to be regulated by U17 snoRNA. Small nucleolar RNAs (snoRNAs) are a class of small RNA molecules that primarily guide chemical modifications... Read more

Business

view channel

License Agreement to Promote Development of Therapeutic CDK Inhibitors

A license agreement has been signed that was designed to promote the development and commercialization of a series of highly-selective cyclin-dependent kinase 7 (CDK7) inhibitors for the treatment of cancer, inflammation, and viral infections. Cyclin-dependent kinases (CDKs) play a pivotal role in cell cycle control... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.